Cetera Investment Advisers’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Buy
387,710
+13,196
+4% +$57K ﹤0.01% 2309
2026
Q1
$1.45M Buy
374,514
+3,250
+0.9% +$13.3K ﹤0.01% 2574
2025
Q4
$1.55M Sell
371,264
-5,457
-1% -$21.1K ﹤0.01% 2435
2025
Q3
$1.24M Buy
376,721
+107,259
+40% +$303K ﹤0.01% 2586
2025
Q2
$383K Sell
269,462
-14,600
-5% -$20.7K ﹤0.01% 3181
2025
Q1
$423K Buy
284,062
+500
+0.2% +$787 ﹤0.01% 2980
2024
Q4
$318K Buy
283,562
+23,250
+9% +$19.8K ﹤0.01% 3075
2024
Q3
$247K Sell
260,312
-7,500
-3% -$9.46K ﹤0.01% 3231
2024
Q2
$423K Buy
267,812
+7,300
+3% +$10.6K ﹤0.01% 2727
2024
Q1
$378K Buy
260,512
+8,937
+4% +$12.8K ﹤0.01% 2834
2023
Q4
$337K Buy
251,575
+10,750
+4% +$12.6K ﹤0.01% 1721
2023
Q3
$342K Buy
240,825
+4,000
+2% +$5.67K ﹤0.01% 1634
2023
Q2
$272K Buy
236,825
+3,500
+2% +$4.13K ﹤0.01% 1809
2023
Q1
$247K Buy
233,325
+71,100
+44% +$103K ﹤0.01% 1824
2022
Q4
$247K Buy
162,225
+1,450
+0.9% +$2.49K ﹤0.01% 1781
2022
Q3
$341K Buy
160,775
+800
+0.5% +$1.69K 0.01% 1198
2022
Q2
$214K Buy
159,975
+10,287
+7% +$15.3K ﹤0.01% 1625
2022
Q1
$316K Buy
149,688
+30,060
+25% +$73.2K ﹤0.01% 1445
2021
Q4
$444K Buy
119,628
+71,224
+147% +$307K 0.01% 1257
2021
Q3
$242K Buy
+48,404
New +$279K ﹤0.01% 1570

Other funds holding PGEN

Cetera Investment Advisers's PGEN Position: Q2 2026 in Review

Cetera Investment Advisers increased its Precigen (PGEN) stake by 3.5% in Q2 2026, buying an estimated $57K and bringing the position to 387,710 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2309.

Cetera Investment Advisers first reported a position in PGEN in Q3 2021 and has held it in 20 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Cetera Investment Advisers held 387,710 shares of Precigen worth $2.21M as of Q2 2026.
  • Cetera Investment Advisers bought 13,196 Precigen shares in Q2 2026, an estimated $57K.
  • Precigen made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2309 holding.
  • Cetera Investment Advisers first reported a position in Precigen in Q3 2021 and has held it in 20 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.